182 related articles for article (PubMed ID: 15339712)
1. Prevalence and characteristics of adolescents patients with co-occurring ADHD and substance dependence.
Gordon SM; Tulak F; Troncale J
J Addict Dis; 2004; 23(4):31-40. PubMed ID: 15339712
[TBL] [Abstract][Full Text] [Related]
2. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
[TBL] [Abstract][Full Text] [Related]
3. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
Kollins SH
J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
[TBL] [Abstract][Full Text] [Related]
4. Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents.
Williams RJ; Goodale LA; Shay-Fiddler MA; Gloster SP; Chang SY
Am J Addict; 2004; 13(4):381-9. PubMed ID: 15370936
[TBL] [Abstract][Full Text] [Related]
5. ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.
Kollins SH
J Atten Disord; 2008 Sep; 12(2):115-25. PubMed ID: 18192623
[TBL] [Abstract][Full Text] [Related]
6. Attention deficit hyperactivity disorder and substance use disorders.
Szobot CM; Bukstein O
Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
[TBL] [Abstract][Full Text] [Related]
7. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
[TBL] [Abstract][Full Text] [Related]
8. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
Upadhyaya HP
J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
[TBL] [Abstract][Full Text] [Related]
9. Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.
Harpin VA
Arch Dis Child Educ Pract Ed; 2008 Apr; 93(2):58-65. PubMed ID: 18356307
[TBL] [Abstract][Full Text] [Related]
10. [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].
Frölich J; Banaschewski T; Spanagel R; Döpfner M; Lehmkuhl G
Z Kinder Jugendpsychiatr Psychother; 2012 Sep; 40(5):287-99; quiz 299-300. PubMed ID: 22869222
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children.
Kociancic T; Reed MD; Findling RL
Expert Opin Drug Saf; 2004 Mar; 3(2):93-100. PubMed ID: 15006715
[TBL] [Abstract][Full Text] [Related]
12. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults.
Faraone SV; Biederman J; Wilens TE; Adamson J
Psychol Med; 2007 Dec; 37(12):1743-52. PubMed ID: 17349106
[TBL] [Abstract][Full Text] [Related]
13. Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder.
Findling RL; Short EJ; Manos MJ
J Am Acad Child Adolesc Psychiatry; 2001 Dec; 40(12):1441-7. PubMed ID: 11765290
[TBL] [Abstract][Full Text] [Related]
14. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
15. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
16. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.
Janols LO; Liliemark J; Klintberg K; von Knorring AL
Nord J Psychiatry; 2009 Nov; 63(6):508-16. PubMed ID: 19958258
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents.
Riggs PD; Hall SK; Mikulich-Gilbertson SK; Lohman M; Kayser A
J Am Acad Child Adolesc Psychiatry; 2004 Apr; 43(4):420-9. PubMed ID: 15187802
[TBL] [Abstract][Full Text] [Related]
18. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
Fone KC; Nutt DJ
Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.
van Emmerik-van Oortmerssen K; van de Glind G; van den Brink W; Smit F; Crunelle CL; Swets M; Schoevers RA
Drug Alcohol Depend; 2012 Apr; 122(1-2):11-9. PubMed ID: 22209385
[TBL] [Abstract][Full Text] [Related]
20. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
